Thanks everyone for commenting and sharing your knowledge with us so far. Some comments have already been made about differences in VPTD and infant mortality between the two ART arms in the study. Specifically, better HIV-free survival was found in infants in the zidovudine-Art versus the tenofovir-ART in period 2. In the discussion, there is brief mention a possible confounder accounting for this result. Could the authors and experts further elaborate on the potential biologic etiology proposed and what specific steps future research should take to better illuminate the pharmacokinetic interaction between drugs taken concomitantly?
Easy one-click social registrationIs this safe?
We only receive the minimum information necessary to verify your account. We never get access to your friends/contacts or your profile, and we never post on your behalf. Your social account is used for logging in only.ORRegister via email
Send me updates on this Contest
In order to ensure a fair voting process and to make sure that no one votes more than once, we ask that you register either with a social networking account (easiest, only requires one click) or by registering with your email address (this will require you to click on a verification email that we will send you).
You only need to register once.